skip to Main Content

Making Cancer Patient Clinical Trial Recruitment & Engagement Easier

Are you struggling to increase clinical trial awareness, recruitment, and participant retention for your oncology drug trials? Building up an efficient pre-screening process becomes an urgent task for companies to connect with potential participants; keep them engaged through the trial…

Applications Open for the 2021 AIM-HI Women’s Venture Competition!

  • March 8, 2021
  • Blog

Today is International Women’s Day. In honor of the occassion, the AIM-HI Accelerator Fund (AIM-HI) would like to highlight for you our venture philanthropy effort to provide critically needed seed funding to an underserved population: women scientist-entrepreneurs devoted to address…

Together, All of Our Actions Matter!

  • February 4, 2021
  • Blog

Every year, people around the world connect on a special day to support and remember the families and individuals affected by cancer. This day is called World Cancer Day, on February 4th. Over the past two decades, World Cancer Day…

AIM-HI Women’s Venture Competition Sponsor: Microsoft

  • December 15, 2020
  • Blog

The AIM-HI Accelerator Fund sincerely thanks Microsoft for being a generous sponsor and supporting our inaugural Women’s Venture Competition program to provide various opportunities to women-led oncology start-ups! Only 2% of all venture money go to women-led early stage companies.…

AIM-HI Portfolio Company Profile: Rasio Therapeutics

  • August 10, 2020
  • Blog

Serial entrepreneur Ken Malone, Ph.D., and his team of scientists and business executives are at the forefront of developing cutting-edge biohealth companies. Malone is the Chairman of the Board of Directors of Rasio Therapeutics, a start-up which is bringing innovative…

AIM-HI Portfolio Company Profile: Tvardi Therapeutics

  • July 29, 2020
  • Blog

Imran Alibhai, Ph.D., is the CEO of Tvardi Therapeutics, a biopharmaceutical company developing breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. The National Foundation for Cancer Research and AIM-HI Accelerator Fund have been early financial supporters of…

Back To Top